RYAN WOOD: Open Payments
NPI 1831941780 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $316 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $131 |
| ABBVIE INC. | 5 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Edwards Lifesciences Corporation | 1 | $69 |
| LEO Pharma Inc. | 2 | $47 |
| UCB, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $30 |
| MIMEDX Group, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: SKYRIZI, DUPIXENT, SAPIEN 3 Ultra RESILIA, LIBTAYO, ADBRY, Bimzelx, RINVOQ, Otezla.
Industry payments across AZ — which companies pay providers there.
